GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9%
Fri, 25 Oct

GSK PHARMA has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:

GSK PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-18*
3
Jun-19*
3
Sep-19*
QoQ ChangeYoY Change
Net SalesRs m8,1637,8808,82111.9%8.1%
Other incomeRs m148305156-48.9%5.3%
TurnoverRs m8,3118,1868,9779.7%8.0%
ExpensesRs m6,5126,2256,87910.5%5.6%
Gross profitRs m1,5341,6555,954259.8%288.2%
DepreciationRs m11519122719.1%97.4%
InterestRs m299-1.1%318.2%
Profit before taxRs m1,5651,7605,874233.7%275.4%
TaxRs m55762684635.2%51.9%
Profit after taxRs m1,0081,1355,028343.1%398.9%
Gross profit margin%18.821.067.5
Effective tax rate%35.635.514.4
Net profit margin%12.113.956.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 8.1% on a year-on-year (YoY) basis. The expenses were up by 5.6% YoY during the same period.
  • The company's operating profit increased by 288.2% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 67.5% in 2QFY20 as against 18.8% in 2QFY19.
  • Depreciation charges increased by 97.4% and finance costs increased by 318.2% YoY, respectively.
  • Other income increased by 5.3% YoY during the quarter.
  • Net profit for the quarter increased by 398.9% YoY. Net profit margins during the quarter increased from 12.1% in 2QFY19 to 56.0% in 2QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 11.9% on a quarter-on-quarter (QoQ) basis. The expenses were up by 10.5% QoQ during the same period.
  • The company's operating profit increased by 259.8% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 67.5% in 2QFY20 as against 21.0% in 1QFY19.
  • Net profit for the quarter increased by 343.1% QoQ, while net profit margins increased from 13.9% in 1QFY19 to 56.0% in 2QFY20.

To see how GSK PHARMA has performed over the last eight quarters,please visit here.

Revealing at 5pm Today: The Great Indian Wealth Project

GSK PHARMA Share Price Performance

Over the last one year,GSK PHARMA share price has moved up from Rs 1,283.6 to Rs 1,507.9, registering a Gain of Rs 224.3 or around 17.5%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,848.3 (down 0.3%). Over the last one year it has moved down from 13,909.4 to 12,848.3, a gain of 1,061 points (down 7.6%).

Overall, the S&P BSE SENSEX is up 14.6% over the year.

Current Valuations

At the current price of Rs 1,507.9, the price to earnings (P/E) ratio of GSK PHARMA stands at 30.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 11.9 times.

Equitymaster requests your view! Post a comment on "GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9%". Click here!

  

Related Views on News

GSK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of GSK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

6 Penny Stocks that Rallied 1,000%+ in One Year(Views On News)

Dec 6, 2021

These penny stocks shed their penny status by surging 1,000% or more in the last one year.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Dec 8, 2021 11:14 AM

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA 8-QTR ANALYSIS

COMPARE GSK PHARMA WITH

MARKET STATS